{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:42:11Z","timestamp":1764906131344,"version":"3.37.3"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"name":"a NIHR Advanced Fellowship","award":["NIHR302258"],"award-info":[{"award-number":["NIHR302258"]}]},{"DOI":"10.13039\/100018645","name":"MRC","doi-asserted-by":"publisher","award":["MR\/101 1808\/1"],"award-info":[{"award-number":["MR\/101 1808\/1"]}],"id":[{"id":"10.13039\/100018645","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wellcome senior research fellowship in clinical science","award":["205039\/Z\/16\/Z"],"award-info":[{"award-number":["205039\/Z\/16\/Z"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205039\/Z\/16\/Z"],"award-info":[{"award-number":["205039\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","award":["grant no. LOND1"],"award-info":[{"award-number":["grant no. LOND1"]}],"id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010756","name":"Health and Social Care Research and Development Division","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001626","name":"Public Health Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001626","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Nonadherence to immune-modifying therapy is a complex behaviour which, before the COVID-19 pandemic, was shown to be associated with mental health disorders in people with immune-mediated diseases. The COVID-19 pandemic has led to a rise in the global prevalence of anxiety and depression, and limited data exist on the association between mental health and nonadherence to immune-modifying therapy during the pandemic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the extent of and reasons underlying nonadherence to systemic immune-modifying therapy during the COVID-19 pandemic in individuals with psoriasis, and the association between mental health and nonadherence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Online self-report surveys (PsoProtectMe), including validated screens for anxiety and depression, were completed globally during the first year of the pandemic. We assessed the association between anxiety or depression and nonadherence to systemic immune-modifying therapy using binomial logistic regression, adjusting for potential cofounders (age, sex, ethnicity, comorbidity) and country of residence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 3980 participants from 77 countries, 1611 (40.5%) were prescribed a systemic immune-modifying therapy. Of these, 408 (25.3%) reported nonadherence during the pandemic, most commonly due to concerns about their immunity. In the unadjusted model, a positive anxiety screen was associated with nonadherence to systemic immune-modifying therapy [odds ratio (OR) 1.37, 95% confidence interval (CI) 1.07\u20131.76]. Specifically, anxiety was associated with nonadherence to targeted therapy (OR 1.41, 95% CI 1.01\u20131.96) but not standard systemic therapy (OR 1.16, 95% CI 0.81\u20131.67). In the adjusted model, although the directions of the effects remained, anxiety was not significantly associated with nonadherence to overall systemic (OR 1.20, 95% CI 0.92\u20131.56) or targeted (OR 1.33, 95% CI 0.94\u20131.89) immune-modifying therapy. A positive depression screen was not strongly associated with nonadherence to systemic immune-modifying therapy in the unadjusted (OR 1.22, 95% CI 0.94\u20131.57) or adjusted models (OR 1.14, 95% CI 0.87\u20131.49).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These data indicate substantial nonadherence to immune-modifying therapy in people with psoriasis during the pandemic, with attenuation of the association with mental health after adjusting for confounders. Future research in larger populations should further explore pandemic-specific drivers of treatment nonadherence. Clear communication of the reassuring findings from population-based research regarding immune-modifying therapy-associated adverse COVID-19 risks to people with psoriasis is essential, to optimize adherence and disease outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljac144","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T14:21:29Z","timestamp":1674224489000},"page":"610-617","source":"Crossref","is-referenced-by-count":4,"title":["Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey"],"prefix":"10.1093","volume":"188","author":[{"given":"Sophia","family":"Quirke-McFarlane","sequence":"first","affiliation":[{"name":"School of Cancer and Pharmaceutical Sciences"},{"name":"School of Psychology, University of Surrey , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Weinman","sequence":"additional","affiliation":[{"name":"School of Cancer and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma S","family":"Cook","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-074X","authenticated-orcid":false,"given":"Zenas Z N","family":"Yiu","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1805-6278","authenticated-orcid":false,"given":"Nick","family":"Dand","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinead M","family":"Langan","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London"},{"name":"Faculty of Epidemiology, and Population Health, London School of Hygiene and Tropical Medicine , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Bechman","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Tsakok","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayleigh J","family":"Mason","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre , Manchester , UK"},{"name":"School of Medicine, Keele University , Keele , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"McAteer","sequence":"additional","affiliation":[{"name":"The Psoriasis Association , Northampton , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Freya","family":"Meynell","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolaji","family":"Coker","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s College London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Vincent","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s College London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Urmston","sequence":"additional","affiliation":[{"name":"The Psoriasis Association , Northampton , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Vesty","sequence":"additional","affiliation":[{"name":"The Psoriasis Association , Northampton , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jade","family":"Kelly","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Lancelot","sequence":"additional","affiliation":[{"name":"International Federation of Psoriasis Associations , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Moorhead","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines A","family":"Barbosa","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2845-4384","authenticated-orcid":false,"given":"Herve","family":"Bachelez","sequence":"additional","affiliation":[{"name":"Department of Dermatology, AP-HP H\u00f4pital Saint-Louis , Paris , France"},{"name":"INSERM U1163, Imagine Institute for Human Genetic Diseases, Universit\u00e9 de Paris , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Capon","sequence":"additional","affiliation":[{"name":"Department of Medical and Molecular Genetics"},{"name":"NIHR Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s College London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia R","family":"Contreras","sequence":"additional","affiliation":[{"name":"Catedra de Dermatologia, Hospital de Clinicas, Facultad de Ciencias Medicas, Universidad Nacional de Asuncion , Paraguay"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"De La Cruz","sequence":"additional","affiliation":[{"name":"Clinica Dermacross , Santiago , Chile"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Di Meglio","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s College London , London , UK"},{"name":"St John\u2019s Institute of Dermatology (School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, University of Verona , Verona , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Jullien","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Edouard Herriot Hospital, Hospices Civils de Lyon, University of Lyon , Lyon , France"},{"name":"Groupe de Recherche sur le Psoriasis (GrPso) de la Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie , Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Ghent University , Ghent , Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Naldi","sequence":"additional","affiliation":[{"name":"Centro Studi GISED , Bergamo , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Llu\u00eds","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Aut\u00f2noma de Barcelona , Barcelona, Catalonia , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis","family":"Spuls","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Amsterdam Public Health\/Infection and Immunology, Amsterdam University Medical Centers , Location AMC, Amsterdam , the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Centro Hospitalar do Porto , Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2918-6481","authenticated-orcid":false,"given":"Richard B","family":"Warren","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoseah","family":"Waweru","sequence":"additional","affiliation":[{"name":"International Federation of Psoriasis Associations , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B","family":"Galloway","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E M","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre , Manchester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan N","family":"Barker","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s College London , London , UK"},{"name":"St John\u2019s Institute of Dermatology (School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1714-9963","authenticated-orcid":false,"given":"Sam","family":"Norton","sequence":"additional","affiliation":[{"name":"Psychology Department (Institute of Psychiatry, Psychology and Neuroscience), King\u2019s College London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9918-1144","authenticated-orcid":false,"given":"Catherine H","family":"Smith","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London"},{"name":"NIHR Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s College London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4692-3794","authenticated-orcid":false,"given":"Satveer K","family":"Mahil","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London"},{"name":"NIHR Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust and King\u2019s College London , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the PsoProtect study group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleema","family":"Alfailakawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wisam","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Andres","family":"Ejarque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen Bugarin","family":"Diz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Grys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahira Hamdy","family":"El Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tran Hong","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Okuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmara","family":"Samselska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Tosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Hsin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"author":"World Health Organization","key":"2023100619295123600_ljac144-B1"},{"volume-title":"Concordance, Adherence and Compliance in Medicine Taking","year":"2005","author":"Horne","key":"2023100619295123600_ljac144-B2"},{"key":"2023100619295123600_ljac144-B3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence","volume":"160","author":"DiMatteo","year":"2000","journal-title":"Arch Intern Med"},{"key":"2023100619295123600_ljac144-B4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2147\/PPA.S50055","article-title":"The influence of symptoms of anxiety and depression on medication nonadherence and its causes: a population based survey of prescription drug users in Sweden","volume":"7","author":"Thunander Sundbom","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"2023100619295123600_ljac144-B5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s11606-011-1704-y","article-title":"Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis","volume":"26","author":"Grenard","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2023100619295123600_ljac144-B6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s12325-015-0256-7","article-title":"A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases","volume":"32","author":"Vangeli","year":"2015","journal-title":"Adv Ther"},{"key":"2023100619295123600_ljac144-B7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin Med"},{"key":"2023100619295123600_ljac144-B8","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071390","article-title":"Biologics for psoriasis during the COVID-19 pandemic","volume":"10","author":"Kamiya","year":"2021","journal-title":"J Clin Med"},{"key":"2023100619295123600_ljac144-B9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jid.2016.08.034","article-title":"Infections in moderate to severe psoriasis patients treated with biological drugs compared to classic systemic drugs: findings from the BIOBADADERM Registry","volume":"137","author":"D\u00e1vila-Seijo","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2023100619295123600_ljac144-B10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bjd.19755","article-title":"Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey","volume":"185","author":"Mahil","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023100619295123600_ljac144-B11","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaad.2020.12.058","article-title":"National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2 \u2013 Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments","volume":"84","author":"Gelfand","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2023100619295123600_ljac144-B12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaci.2020.10.007","article-title":"Factors associated with adverse COVID-19 outcomes in patients with psoriasis \u2013 insights from a global registry-based study","volume":"147","author":"Mahil","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2023100619295123600_ljac144-B13","doi-asserted-by":"crossref","first-page":"e2129639","DOI":"10.1001\/jamanetworkopen.2021.29639","article-title":"Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19","volume":"4","author":"Izadi","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2023100619295123600_ljac144-B14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/annrheumdis-2020-219498","article-title":"Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"80","author":"Strangfeld","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2023100619295123600_ljac144-B15","doi-asserted-by":"crossref","first-page":"e049740","DOI":"10.1136\/bmjopen-2021-049740","article-title":"Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD","volume":"11","author":"Sperger","year":"2021","journal-title":"BMJ Open"},{"key":"2023100619295123600_ljac144-B16","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1016\/S2665-9913(22)00098-4","article-title":"Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform","volume":"4","author":"MacKenna","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2023100619295123600_ljac144-B17","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14691","article-title":"The impact of COVID-19 in patients with psoriasis: a multicenter study in Istanbul","volume":"34","author":"Kara Polat","year":"2021","journal-title":"Dermatol Ther"},{"key":"2023100619295123600_ljac144-B18","doi-asserted-by":"crossref","first-page":"e682\u20134","DOI":"10.1111\/jdv.16771","article-title":"Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic","volume":"34","author":"Rob","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023100619295123600_ljac144-B19","doi-asserted-by":"crossref","first-page":"e673\u20135","DOI":"10.1111\/jdv.16759","article-title":"Treatment adherence in psoriatic patients during COVID-19 pandemic: real-world data from a tertiary hospital in Greece","volume":"34","author":"Vakirlis","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023100619295123600_ljac144-B20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000513575","article-title":"Biologic therapies, psoriasis, and COVID-19: our experience at the Psoriasis Unit of the University of Naples Federico II","volume":"237","author":"Camela","year":"2021","journal-title":"Dermatology"},{"key":"2023100619295123600_ljac144-B21","doi-asserted-by":"crossref","DOI":"10.2147\/PPA.S263843","article-title":"Nonadherence to treatment and patient-reported outcomes of psoriasis during the COVID-19 epidemic: a web-based survey","volume":"14","author":"Wang","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"2023100619295123600_ljac144-B22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jocd.14610","article-title":"Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: a multicenter study","volume":"21","author":"Oguz Topal","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"2023100619295123600_ljac144-B23","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1080\/09546634.2021.1927947","article-title":"The impact of COVID-19 pandemic on psoriasis patients, and their immunosuppressive treatment: a cross-sectional multicenter study from Turkey","volume":"33","author":"Kartal","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2023100619295123600_ljac144-B24","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1111\/jocd.14381","article-title":"Treatment of psoriasis with biologics in the early COVID-19 pandemic: a study examining patient attitudes toward the treatment and disease course","volume":"20","author":"Yalici-Armagan","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"2023100619295123600_ljac144-B25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2020.08.001","article-title":"Impact of COVID-19 pandemic on mental health in the general population: a systematic review","volume":"277","author":"Xiong","year":"2020","journal-title":"J Affect Disord"},{"key":"2023100619295123600_ljac144-B26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12992-020-00589-w","article-title":"Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis","volume":"16","author":"Salari","year":"2020","journal-title":"Global Health"},{"key":"2023100619295123600_ljac144-B27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jad.2021.06.073","article-title":"A systematic review of the prevalence of anxiety among the general population during the COVID-19 pandemic","volume":"293","author":"Pashazadeh Kan","year":"2021","journal-title":"J Affect Disord"},{"key":"2023100619295123600_ljac144-B28","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"key":"2023100619295123600_ljac144-B29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann Intern Med"},{"key":"2023100619295123600_ljac144-B30","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The Patient Health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"key":"2023100619295123600_ljac144-B31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2023100619295123600_ljac144-B32","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.1111\/jdv.17450","article-title":"Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study","volume":"35","author":"Mahil","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023100619295123600_ljac144-B33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/09546634.2011.607425","article-title":"Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities","volume":"24","author":"Chan","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"2023100619295123600_ljac144-B34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jid.2017.11.015","article-title":"Intentional and unintentional medication non-adherence in psoriasis: the role of patients\u2019 medication beliefs and habit strength","volume":"138","author":"Thorneloe","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2023100619295123600_ljac144-B35","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13434","article-title":"COVID-19 and psoriasis: should we fear for patients treated with biologics?","volume":"33","author":"Amerio","year":"2020","journal-title":"Dermatol Ther"},{"key":"2023100619295123600_ljac144-B36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/annrheumdis-2020-218946","article-title":"Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"80","author":"Akiyama","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2023100619295123600_ljac144-B37","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1080\/09546634.2020.1770165","article-title":"A survey of psoriasis patients on biologics during COVID-19: a single centre experience","volume":"33","author":"Burlando","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2023100619295123600_ljac144-B38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2021.08.065","article-title":"Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: a retrospective matched cohort study from Massachusetts","volume":"86","author":"Pahalyants","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"2023100619295123600_ljac144-B39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjd.15086","article-title":"Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis","volume":"176","author":"Thorneloe","year":"2017","journal-title":"Br J Dermatol"},{"key":"2023100619295123600_ljac144-B40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1346-8138.15727","article-title":"Psoriasis: recent progress in molecular-targeted therapies","volume":"48","author":"Honma","year":"2021","journal-title":"J Dermatol"},{"key":"2023100619295123600_ljac144-B41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MLR.0b013e31819a5acc","article-title":"Physician communication and patient adherence to treatment: a meta-analysis","volume":"47","author":"Haskard Zolnierek","year":"2009","journal-title":"Med Care"},{"key":"2023100619295123600_ljac144-B42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl Behav Med"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljac144\/49275530\/ljac144.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/188\/5\/610\/51917934\/ljac144.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/188\/5\/610\/51917934\/ljac144.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T19:31:41Z","timestamp":1696620701000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/188\/5\/610\/6957428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,12,23]]},"published-print":{"date-parts":[[2023,4,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljac144","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"type":"print","value":"0007-0963"},{"type":"electronic","value":"1365-2133"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2022,12,23]]}}}